FDA Approves Amgen's Cholesterol-Lowering Drug Repatha
August 27, 2015 at 18:31 PM EDT
The U.S. Food and Drug Administration on Thursday approved Amgen Inc's Repatha drug for patients with hereditary forms of high cholesterol and those with cardiovascular disease.